Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biochemistry|December 23, 2017
Structural Evidence of a Major Conformational Change Triggered by Substrate Binding in DapE Enzymes: Impact on the Catalytic MechanismBoguslaw Nocek, Cory Reidl, Anna Starus, et al.
Plos One|May 9, 2014
The dimerization domain in DapE enzymes is required for catalysisBoguslaw Nocek, Anna Starus, Magdalena Makowska-Grzyska, et al.
Antibiotics (Basel, Switzerland)|September 16, 2020
Indoline-6-Sulfonamide Inhibitors of the Bacterial Enzyme DapECory T Reidl, Tahirah K Heath, Iman Darwish, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2023
Tetrazole-based inhibitors of the bacterial enzyme N-succinyl-l,l-2,6-diaminopimelic acid desuccinylase as potential antibioticsThomas DiPuma, Teerana Thabthimthong, Emma H Kelley, et al.
Biochemistry|July 18, 2015
Inhibition of the dapE-Encoded N-Succinyl-L,L-diaminopimelic Acid Desuccinylase from Neisseria meningitidis by L-CaptoprilAnna Starus, Boguslaw Nocek, Brian Bennett, et al.
Bioorganic & Medicinal Chemistry|March 9, 2026
N-aryl sulfonamide inhibitors of the bacterial enzyme diaminopimelate desuccinylase (DapE) as potential new antibioticsSebastian Flieger, Emma H Kelley, Thahani S Habeeb Mohammad, et al.
Therapeutic Advances in Medical Oncology|December 8, 2022
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete responseNikaoly Ciriaco, Esther Zamora, Santiago Escrivá-de-Romaní, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2025
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal CancerAri J Rosenberg, Evgeny Izumchenko, Aditya Juloori, et al.
Oral Oncology|June 27, 2025
Analytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNASamaneh Eickelschulte, Anna Starus, David H Murray, et al.
JAMA Oncology|June 6, 2024
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled TrialAri J Rosenberg, Nishant Agrawal, Aditya Juloori, et al.
Pageof 1